Drugs / HIV-CAR-T
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06880380 | Sep 2025 → Mar 2026 overdue | HIV infectious disease | Institute of Hematology & Blood Diseases Hospital, China | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HIV-CAR-T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06880380 ↗ |
| Modality | Cell therapy | “Autologous CAR-T cell therapy in HIV-1/AIDS patients” NCT06880380 ↗ |
| Route | Intravenous | “Intravenous Infusion of CAR-T Cells” NCT06880380 ↗ |